FDA

27 August 2026

Rasonque pancreatic cancer drug wins FDA approval

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

22 April 2026

Oral Phenylephrine Phase-Out Puts OTC Brands Under Review

Oral Phenylephrine Phase-Out debate grows as Sahpra weighs evidence, industry warns on access, and pharmacists call for a gradual transition.

23 March 2026

Animal Testing Alternatives: New FDA Guidance Insights

Learn how Animal Testing Alternatives can accelerate R&D and improve human relevance in safety data and drug development.

11 March 2026

FDA Biosimilar Development Guidance Targets Treatment Costs

Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.

16 February 2026

FDA Unpredictable: Moderna Challenges the Agency

Moderna criticises the FDA as unpredictable, impacting its mRNA flu shot and the future of drug innovation in America.

7 October 2025

FDA Generic Drug Review Boosts US Drug Manufacturing

18 September 2025

HHS Restructuring Plan Blocked by Federal Court

The HHS restructuring plan faced a major setback as the court intervened, stopping job cuts and agency overhaul efforts.

29 June 2025

Are New Cancer Treatments Worth the Price?

Learn about the cost of cancer treatments and the reality behind their effectiveness. Are patients getting the care they deserve?

24 March 2025

FDA warns Aspen Pharmacare over eye drop production standards

The US FDA has warned Aspen Pharmacare, Africa's largest drugmaker, citing breaches in manufacturing standards for eye drops produced at its Gqeberha facility.

FDA